Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996

Autor: Göran Gustafsson, Jon Kristinsson, M Yssing, Stanislaw Garwicz, Mikko Perkkiö, Ulla M. Saarinen-Pihkala, Niels Clausen, P. J. Moe, A Kreuger, Sverre O. Lie

Publikováno v: Acta Paediatrica. 87:1151-1161

In a multinational, population-based study from the five Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), 2648 children below 15 y of age were diagnosed with acute lymphoblastic leukaemia (ALL) in the years 1981-1996. The annual incid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71861b89fadccfd160c5689e04c50975
https://doi.org/10.1111/j.1651-2227.1998.tb00923.x

Medulloblastoma in Nordic Children. II Neurologic and Social Prognosis in Long Term Survivors

Autor: A. Glomstein, G. Jonmundsson, M Yssing, Stanislaw Garwicz, S. Kruus

Publikováno v: Acta Paediatrica. 79:12-19

Forty-four Nordic children surviving from histologically documented medulloblastoma diagnosed before the age of 15 years from 1968 to 1977 were studied by clinical investigations 5–15 years after the time of diagnosis. Thirty percent of the childre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c0876001a6fa20241efa20d5f652c6ab
https://doi.org/10.1111/j.1651-2227.1990.tb17307.x

Long-term results in children with AML: NOPHO-AML study group - report of three consecutive trials

Autor: Martti A. Siimes, Niels Clausen, Liisa Hovi, M Yssing, Bem Zeller, Jonas Abrahamsson, Henrik Hasle, Guðmundur K Jónmundsson, Lotta Mellander, Göran Gustafsson, S. O. Lie, Erik Forestier

Publikováno v: Lie, SO, Abrahamsson, J, Clausen, N, Forestier, E, Hasle, H, Hovi, L, Jonmundsson, G, Mellander, L, Siimes, MA, Yssing, M, Zeller, B & Gustafsson, G 2005, ' Long-term results in children with AML: NOPHO-AML study group-report of three consecutive trials ', Leukemia, vol. 19, pp. 2090-2100 .

In all, 447 children with acute myeloid leukaemia (AML) have been treated on three consecutive NOPHO studies from July 1984 to December 2001. NOPHO-AML 84 was of moderate intensity with an induction of three courses of cytarabine, 6-thioguanine and d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93dbbdd54c8db15e3caec1814ce1c12
https://pure.au.dk/portal/da/publications/longterm-results-in-children-with-aml-nophoaml-study-group--report-of-three-consecutive-trials(abceefd0-c31b-11da-bee9-02004c4f4f50).html

Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO)

Autor: G, Gustafsson, A, Kreuger, N, Clausen, S, Garwicz, J, Kristinsson, S O, Lie, P J, Moe, M, Perkkiö, M, Yssing, U M, Saarinen-Pihkala

Publikováno v: Acta paediatrica (Oslo, Norway : 1992). 87(11)

In a multinational, population-based study from the five Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), 2648 children below 15 y of age were diagnosed with acute lymphoblastic leukaemia (ALL) in the years 1981-1996. The annual incid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::114670760b3bbe41e94d66046bf7f427
https://pubmed.ncbi.nlm.nih.gov/10342529

[Acute lymphoblastic leukemia in children. A retrospective study: 1970-1991]

Autor: K, Schmiegelow, M, Yssing, H, Hertz, B, Scherling, K, Holm, M, Schmiegelow

Publikováno v: Ugeskrift for laeger. 157(1)

From January 1970 through December 1991, 94 girls and 130 boys with a median age of 4.8 years were diagnosed with non-B cell acute lymphoblastic leukaemia (ALL) at the University Hospital, Rigshospitalet. Intensive risk-group adapted therapy based on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2273e5afb3b7a2eb246016272124c0f1
https://pubmed.ncbi.nlm.nih.gov/7839546